The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Etoflam 5% w/w Gel

Phoenix LabsPA1113/002/001

Main Information

Trade NameEtoflam 5% w/w Gel
Active SubstancesEtofenamate
Dosage FormGel
Licence HolderPhoenix Labs
Licence NumberPA1113/002/001

Group Information

ATC CodeM02AA Antiinflammatory preparations, non-steroids for topical use
M02AA06 etofenamate


License statusAuthorised
Licence Issued04/04/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back